The Journal of Bone and Joint Surgery (American) 83:S48-S55 (2001)
© 2001 The Journal of Bone and Joint Surgery, Inc.
Intimate Relationship Between TGF-ß/BMP Signaling and Runt Domain Transcription Factor, PEBP2/CBF
Suk-Chul Bae,
Kycong-Sook Lee,
Yu-Wen Zhang and
Yoshiaki Ito
Investigation performed at the Department of Biochemistry, School
of Medicine, and Medical Research Institute, Chungbuk National University,
Cheongju, Korea; and the Department of Viral Oncology, Institute
for Virus Research, Kyoto University, Kyoto, Japan
Suk-Chul Bae
Kycong-Sook Lee
Department of Biochemistry, School of Medicine, Chungbuk National
University, Cheongju, Korea 361-763
Yoshiaki Ito
Yu-Wen Zhang
Department of Viral Oncology, Institute for Virus Research, Kyoto
University, Sakyo-ku, Kyoto 606-8507, Japan. E-mail address for
Yoshiaki Ito: yito{at}virus.kyoto-u.ac.jp
In support of their research or preparation of this manuscript, one
or more of the authors received grants or outside funding from Basic
Research Program of the Korea Science and Engineering Foundation
and Grant-in-Aid 09253220 for Priority Area in Cancer Research from
the Ministry of Education, Science, Sports and Culture, Japan. None
of the authors received payments or other benefits or a commitment
or agreement to provide such benefits from a commercial entity.
No commercial entity paid or directed, or agreed to pay or direct,
any benefits to any research fund, foundation, educational institution, or
other charitable or nonprofit organization with which the authors
are affiliated or associated.
Background:
When C2C12 pluripotent mesenchymal precursor cells are treated
with transforming growth factor-ß1 (TGF-ß1), terminal differentiation
into myotubes is blocked. Treatment with bone morphogenetic protein-2
(BMP-2) not only blocks myogenic differentiation but also induces
osteoblastic differentiation. However, the molecular mechanisms
governing the ability of TGF-ß and BMP to induce ligand-specific
responses and inhibit myogenic differentiation are not known. The objective
of our studies was to elucidate the molecular mechanisms that block
myoblastic differentiation and induce osteoblastic differentiation
in C2C12 cells.
Methods:
Induction of RUNX2/PEBP2 A/Cbfa1 by TGF-ß and BMP was examined
by electrophoretic mobility shift assay (EMSA) and Northern blot
analysis. C2C12 cells stably expressing RUNX2 or Smad, or both,
were established, and the role of these genes in the process of
osteoblastic differentiation was analyzed by examining the expression
of osteoblast-specific markers.
Results:
Treatment of C2C12 with TGF-ß and BMP-induced RUNX2/PEBP2 A/Cbfa1,
a global regulator of osteogenesis. Cooperation between RUNX2 and
BMP-activated Smad induced osteoblastic differentiation.
Conclusions:
Both TGF-ß and BMP activate transcription of RUNX2, which is
sufficient to inhibit myogenesis. To induce osteogenesis, BMP-induced
RUNX2 must cooperate with BMP-activated Smads.

CiteULike Connotea Del.icio.us Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. N. Zacks, Y. Han, Y. Zeng, and A. Swaroop
Activation of signaling pathways and stress-response genes in an experimental model of retinal detachment.
Invest. Ophthalmol. Vis. Sci.,
April 1, 2006;
47(4):
1691 - 1695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gilbert, X. He, P. Farmer, J. Rubin, H. Drissi, A. J. van Wijnen, J. B. Lian, G. S. Stein, and M. S. Nanes
Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) Is Inhibited by Tumor Necrosis Factor-alpha
J. Biol. Chem.,
January 18, 2002;
277(4):
2695 - 2701.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|